By Torres C.   Otero C.   in Enzyme and Microbial Technology

ISSN:0141-0229|29|1|3-12

Elsevier‎(2001)‎

Access to resources Favorite 9.456257

By Torres C.   Otero C.   in Enzyme and Microbial Technology

ISSN:0141-0229|19|8|594-600

Elsevier‎(1996)‎

Access to resources Favorite 9.456257

By Torres C.   Otero C.   in Enzyme and Microbial Technology

ISSN:0141-0229|25|8|745-752

Elsevier‎(1999)‎

Access to resources Favorite 9.456257

By Fernandez-Perez M.   Otero C.   in Enzyme and Microbial Technology

ISSN:0141-0229|28|6|527-536

Elsevier‎(2001)‎

Access to resources Favorite 8.099745

By Fernandez-Perez M.   Otero C.   in Enzyme and Microbial Technology

ISSN:0141-0229|33|5|650-660

Elsevier‎(2003)‎

Access to resources Favorite 8.099745

By Arcos J.A.   Bernabe M.   Otero C.   in Enzyme and Microbial Technology

ISSN:0141-0229|22|1|27-35

Elsevier‎(1998)‎

Access to resources Favorite 7.4411516

By Torres C.   Bernabe M.   Otero C.   in Enzyme and Microbial Technology

ISSN:0141-0229|25|8|753-761

Elsevier‎(1999)‎

Access to resources Favorite 7.4411516

By del-Val M.I.   Otero C.   in Enzyme and Microbial Technology

ISSN:0141-0229|33|1|118-126

Elsevier‎(2003)‎

Access to resources Favorite 7.4411516

By Otero C.   Berrendero M.   Cardenas F.   Alvarez E.   Elson S.   in Applied Biochemistry and Biotechnology

ISSN:0273-2289|120|3|209-223

Humana Press, Inc‎(2005)‎

Access to resources Favorite 6.08464

Oral Ascorbic Acid and Alpha-Tocopherol to Reduce Behavioural Problems in Young Patients Affected of Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Phase II Pilot Trial‎

By Y. de Diego Otero C. Quintero-Navarro Rocio Calvo-Medina R. Heredia-Farfan  

IntechOpen‎(2012)‎

Access to resources Favorite 5.0770874